뇌심부 자극기기 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별 규모, 점유율 및 성장 분석과 예측(2026-2033년)

Global Deep Brain Stimulation Devices Market size was valued at USD 1.68 Billion in 2024 and is poised to grow from USD 1.83 Billion in 2025 to USD 3.71 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The global deep brain stimulation devices market is experiencing significant growth, influenced by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor. This growing health concern has heightened the demand for effective treatments like deep brain stimulation. Technological innovations within the field, including rechargeable devices and enhanced targeting systems, have improved treatment outcomes, safety, and efficacy. Increasing acceptance of deep brain stimulation as a viable therapeutic option among patients and healthcare providers is further driving market expansion, as it offers substantial benefits like symptom relief and reduced medication reliance. Additionally, favorable reimbursement policies and rising healthcare investments in both developed and emerging markets present robust opportunities for manufacturers to broaden their reach and enhance their product offerings effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segments Analysis

Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market is propelled by continual innovations in technology that enhance patient outcomes and broaden the spectrum of treatable conditions. Recent advancements have led to the creation of more accurate targeting systems and refined stimulation parameters, in addition to the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological enhancements facilitate personalized treatment strategies, leading to improved symptom management, greater overall efficacy, and minimized side effects. As a result, the therapy is becoming increasingly effective and safe, contributing to the growing adoption of deep brain stimulation devices across various medical disciplines.

Restraints in the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market faces significant restraints primarily due to the intricate nature of these devices and the precision required for their surgical implantation. The expenses associated with the devices, which encompass the hardware, leads, and related programming systems, can be considerable. Furthermore, the surgical procedures themselves involve high costs, necessitating specialized equipment, dedicated operating room resources, and comprehensive post-operative care. Such financial burdens create barriers to affordability and accessibility, especially in areas where healthcare resources are scarce or insurance coverage is insufficient, limiting the potential reach and adoption of deep brain stimulation technologies.

Market Trends of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation (DBS) Devices market is experiencing significant growth, primarily fueled by the rising prevalence of neurological disorders such as Parkinson's disease, essential tremor, and dystonia. Contributing factors include an aging population, the surge in chronic disease prevalence, and heightened exposure to environmental toxins. As patients and healthcare providers increasingly turn to DBS as a highly effective treatment option, the demand for these devices is expected to expand. This trend underscores the critical role of advanced medical technologies in addressing complex neurological challenges, positioning the DBS market for continued innovation and investment in the foreseeable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Single-channel DBS Devices
• Dual-channel DBS Devices

Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Epilepsy
• Pain Management
• Essential Tremor
• Obsessive Compulsive Disorder (OCD)
• Parkinson's Disease
• Depression
• Dystonia
• Others

Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers
• Others

Global Deep Brain Stimulation Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic Plc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainsway Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Neuromodulation Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Pinchi Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SceneRay Corporation Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapiens Steering Brain Stimulation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Brain Innovations LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newronika S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim Company Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinduction Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations